HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:DOC • US42250P1030
16.725 USD
+0.28 (+1.67%)
Last: Feb 4, 2026, 03:25 PM
We assign a fundamental rating of 3 out of 10 to DOC. DOC was compared to 124 industry peers in the Diversified REITs industry. DOC has a bad profitability rating. Also its financial health evaluation is rather negative. DOC is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- DOC had positive earnings in the past year.
- In the past year DOC had a positive cash flow from operations.
- DOC had positive earnings in 4 of the past 5 years.
- Of the past 5 years DOC 4 years had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -0.20%, DOC is doing worse than 61.29% of the companies in the same industry.
- With a Return On Equity value of -0.51%, DOC is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
- DOC has a Return On Invested Capital (2.23%) which is in line with its industry peers.
- The Average Return On Invested Capital over the past 3 years for DOC is in line with the industry average of 3.05%.
- The last Return On Invested Capital (2.23%) for DOC is above the 3 year average (2.19%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.2% | ||
| ROE | -0.51% | ||
| ROIC | 2.23% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
1.3 Margins
- In the last couple of years the Profit Margin of DOC has grown nicely.
- DOC has a Operating Margin (18.19%) which is comparable to the rest of the industry.
- DOC's Operating Margin has declined in the last couple of years.
- With a Gross Margin value of 60.08%, DOC is not doing good in the industry: 66.94% of the companies in the same industry are doing better.
- DOC's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.19% | ||
| PM (TTM) | N/A | ||
| GM | 60.08% |
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DOC is destroying value.
- There is no outstanding debt for DOC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of 0.30, we must say that DOC is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of 0.30, DOC is not doing good in the industry: 62.90% of the companies in the same industry are doing better.
- The Debt to FCF ratio of DOC is 20.30, which is on the high side as it means it would take DOC, 20.30 years of fcf income to pay off all of its debts.
- DOC has a Debt to FCF ratio of 20.30. This is in the better half of the industry: DOC outperforms 76.61% of its industry peers.
- A Debt/Equity ratio of 1.20 is on the high side and indicates that DOC has dependencies on debt financing.
- With a Debt to Equity ratio value of 1.20, DOC perfoms like the industry average, outperforming 54.84% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.2 | ||
| Debt/FCF | 20.3 | ||
| Altman-Z | 0.3 |
ROIC/WACC0.35
WACC6.33%
2.3 Liquidity
- A Current Ratio of 0.11 indicates that DOC may have some problems paying its short term obligations.
- DOC has a worse Current ratio (0.11) than 95.16% of its industry peers.
- DOC has a Quick Ratio of 0.11. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of DOC (0.11) is worse than 95.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 |
3. Growth
3.1 Past
- DOC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
- The earnings per share for DOC have been decreasing by -16.06% on average. This is quite bad
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.07%
3.2 Future
- The Earnings Per Share is expected to grow by 1.32% on average over the next years.
- The Revenue is expected to grow by 5.02% on average over the next years.
EPS Next Y-24.56%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
EPS Next 5Y1.32%
Revenue Next Year1.33%
Revenue Next 2Y1.76%
Revenue Next 3Y2.62%
Revenue Next 5Y5.02%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 47.79, the valuation of DOC can be described as expensive.
- DOC's Price/Earnings ratio is in line with the industry average.
- The average S&P500 Price/Earnings ratio is at 28.18. DOC is valued rather expensively when compared to this.
- With a Price/Forward Earnings ratio of 63.34, DOC can be considered very expensive at the moment.
- DOC's Price/Forward Earnings ratio is in line with the industry average.
- DOC's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.51.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.79 | ||
| Fwd PE | 63.34 |
4.2 Price Multiples
- DOC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DOC is cheaper than 69.35% of the companies in the same industry.
- 74.19% of the companies in the same industry are more expensive than DOC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.83 | ||
| EV/EBITDA | 12.96 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
5. Dividend
5.1 Amount
- DOC has a Yearly Dividend Yield of 7.42%, which is a nice return.
- DOC's Dividend Yield is a higher than the industry average which is at 6.98.
- Compared to an average S&P500 Dividend Yield of 1.83, DOC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.42% |
5.2 History
- The dividend of DOC decreases each year by -2.76%.
- DOC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-2.76%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- The earnings of DOC are negative and hence is the payout ratio. DOC will probably not be able to sustain this dividend level.
DP-2176.08%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
NYSE:DOC (2/4/2026, 3:25:04 PM)
16.725
+0.28 (+1.67%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-02 2026-02-02/amc
Earnings (Next)04-22 2026-04-22
Inst Owners97.22%
Inst Owner Change0%
Ins Owners0.22%
Ins Owner Change0.5%
Market Cap11.62B
Revenue(TTM)N/A
Net Income(TTM)-38.93M
Analysts75.83
Price Target20.27 (21.2%)
Short Float %3.7%
Short Ratio3.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.42% |
Yearly Dividend1.28
Dividend Growth(5Y)-2.76%
DP-2176.08%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17 2026-03-17 (0.10167)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.17%
Min EPS beat(2)-19.41%
Max EPS beat(2)37.75%
EPS beat(4)2
Avg EPS beat(4)-12.11%
Min EPS beat(4)-79.16%
Max EPS beat(4)37.75%
EPS beat(8)5
Avg EPS beat(8)12.39%
EPS beat(12)7
Avg EPS beat(12)15.73%
EPS beat(16)10
Avg EPS beat(16)43.13%
Revenue beat(2)1
Avg Revenue beat(2)0.28%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)0.94%
Revenue beat(4)3
Avg Revenue beat(4)0.74%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)2.05%
Revenue beat(8)6
Avg Revenue beat(8)1.89%
Revenue beat(12)8
Avg Revenue beat(12)-4.75%
Revenue beat(16)11
Avg Revenue beat(16)-3.38%
PT rev (1m)-2.61%
PT rev (3m)-5.03%
EPS NQ rev (1m)-0.82%
EPS NQ rev (3m)0.75%
EPS NY rev (1m)-1.12%
EPS NY rev (3m)1.57%
Revenue NQ rev (1m)-0.54%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.79 | ||
| Fwd PE | 63.34 | ||
| P/S | 4.15 | ||
| P/FCF | 25.83 | ||
| P/OCF | 9.37 | ||
| P/B | 1.53 | ||
| P/tB | 1.66 | ||
| EV/EBITDA | 12.96 |
EPS(TTM)0.35
EY2.09%
EPS(NY)0.26
Fwd EY1.58%
FCF(TTM)0.65
FCFY3.87%
OCF(TTM)1.79
OCFY10.68%
SpS4.03
BVpS10.93
TBVpS10.05
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.2% | ||
| ROE | -0.51% | ||
| ROCE | 2.83% | ||
| ROIC | 2.23% | ||
| ROICexc | 2.25% | ||
| ROICexgc | 2.46% | ||
| OM | 18.19% | ||
| PM (TTM) | N/A | ||
| GM | 60.08% | ||
| FCFM | 16.06% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
ROICexc(3y)2.2%
ROICexc(5y)1.94%
ROICexgc(3y)2.39%
ROICexgc(5y)2.1%
ROCE(3y)2.77%
ROCE(5y)2.44%
ROICexgc growth 3Y3.4%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y2.73%
ROICexc growth 5Y2.33%
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
F-Score4
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.2 | ||
| Debt/FCF | 20.3 | ||
| Debt/EBITDA | 5.78 | ||
| Cap/Depr | 73.87% | ||
| Cap/Sales | 28.24% | ||
| Interest Coverage | 1.93 | ||
| Cash Conversion | 78.53% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 | ||
| Altman-Z | 0.3 |
F-Score4
WACC6.33%
ROIC/WACC0.35
Cap/Depr(3y)101.04%
Cap/Depr(5y)178.11%
Cap/Sales(3y)35.69%
Cap/Sales(5y)67.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
EPS Next Y-24.56%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
EPS Next 5Y1.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.07%
Revenue Next Year1.33%
Revenue Next 2Y1.76%
Revenue Next 3Y2.62%
Revenue Next 5Y5.02%
EBIT growth 1Y-12.91%
EBIT growth 3Y9.55%
EBIT growth 5Y8.14%
EBIT Next Year227.22%
EBIT Next 3Y51.03%
EBIT Next 5Y31.86%
FCF growth 1Y542.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.14%
OCF growth 3Y10.42%
OCF growth 5Y4.82%
HEALTHPEAK PROPERTIES INC / DOC FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 3 / 10 to DOC.
What is the valuation status for DOC stock?
ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
Can you provide the profitability details for HEALTHPEAK PROPERTIES INC?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 3 / 10.
What is the valuation of HEALTHPEAK PROPERTIES INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for HEALTHPEAK PROPERTIES INC (DOC) is 47.79 and the Price/Book (PB) ratio is 1.53.
How sustainable is the dividend of HEALTHPEAK PROPERTIES INC (DOC) stock?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is -2176.08%.